4//SEC Filing
Mahal Jeetinder Singh 4
Accession 0001213900-24-052215
CIK 0001788028other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 9:40 PM ET
Size
15.7 KB
Accession
0001213900-24-052215
Insider Transaction Report
Form 4
Mahal Jeetinder Singh
Chief Operating Officer
Transactions
- Exercise/Conversion
Voting Common Stock
2024-06-12$7.10/sh+900$6,390→ 25,909 total - Sale
Voting Common Stock
2024-06-12$24.16/sh−900$21,740→ 25,009 total - Exercise/Conversion
Stock Option (right to buy)
2024-06-12+900→ 15,572 totalExercise: $7.10Exp: 2030-05-31→ Voting Common Stock (900 underlying)
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.975 to $24.555, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
- [F3]25% of the original number of shares subject to the option vested on December 12, 2020, and 1/48th of the original number of shares subject to the option vested monthly thereafter.
Issuer
Jasper Therapeutics, Inc.
CIK 0001788028
Entity typeother
Related Parties
1- filerCIK 0001882877
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 9:40 PM ET
- Size
- 15.7 KB